Role of glycated low density lipoprotein in mesangial extracellular matrix synthesis.
Ha
H
H
Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.
Kamanna
V S
VS
Kirschenbaum
M A
MA
Kim
K H
KH
D000818:Animals; D002460:Cell Line; D005109:Extracellular Matrix / Q000201:enzymology*; D005353:Fibronectins / Q000032:analysis / Q000096:biosynthesis / Q000235:genetics; D015870:Gene Expression / Q000187:drug effects / Q000502:physiology; D005920:Glomerular Mesangium / Q000166:cytology / Q000378:metabolism*; D017127:Glycation End Products, Advanced; D006031:Glycosylation; D006801:Humans; D008077:Lipoproteins, LDL / Q000494:pharmacology*; D051379:Mice; D008822:Mice, Transgenic; D011493:Protein Kinase C / Q000378:metabolism; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D016212:Transforming Growth Factor beta / Q000378:metabolism; D000093844:Glycated Proteins
D005353:Fibronectins; D017127:Glycation End Products, Advanced; D008077:Lipoproteins, LDL; D011493:Protein Kinase C; D011505:Protein-Tyrosine Kinases; D012333:RNA, Messenger; D016212:Transforming Growth Factor beta; C031797:glycated lipoproteins, LDL; D000093844:Glycated Proteins